The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal
Open accessAbstract
BACKGROUND: The continued advance of antibiotic resistance threatens the treatment and control of many infectious diseases. This is exemplified by the largest global outbreak of extensively drug-resistant (XDR) tuberculosis (TB) identified in Tugela Ferry, KwaZulu-Natal, South Africa, in 2005 that continues today. It is unclear whether the emergence of XDR-TB in KwaZulu-Natal was due to recent inadequacies in TB control in conjunction with HIV or other factors. Understanding the origins of drug resistance in this fatal outbreak of XDR will inform the control and prevention of drug-resistant TB in other settings. In this study, we used whole genome sequencing and dating analysis to determine if XDR-TB had emerged recently or had ancient antecedents. METHODS AND FINDINGS: We performed whole genome sequencing and drug susceptibility testing on 337 clinical isolates of Mycobacterium tuberculosis collected in KwaZulu-Natal from 2008 to 2013, in addition to three historical isolates, collected from patients in the same province and including an isolate from the 2005 Tugela Ferry XDR outbreak, a multidrug-resistant (MDR) isolate from 1994, and a pansusceptible isolate from 1995. We utilized an array of whole genome comparative techniques to assess the relatedness among strains, to establish the order of acquisition of drug resistance mutations, including the timing of acquisitions leading to XDR-TB in the LAM4 spoligotype, and to calculate the number of independent evolutionary emergences of MDR and XDR. Our sequencing and analysis revealed a 50-member clone of XDR M. tuberculosis that was highly related to the Tugela Ferry XDR outbreak strain. We estimated that mutations conferring isoniazid and streptomycin resistance in this clone were acquired 50 y prior to the Tugela Ferry outbreak (katG S315T [isoniazid]; gidB 130 bp deletion [streptomycin]; 1957 [95% highest posterior density (HPD): 1937-1971]), with the subsequent emergence of MDR and XDR occurring 20 y (rpoB L452P [rifampicin]; pncA 1 bp insertion [pyrazinamide]; 1984 [95% HPD: 1974-1992]) and 10 y (rpoB D435G [rifampicin]; rrs 1400 [kanamycin]; gyrA A90V [ofloxacin]; 1995 [95% HPD: 1988-1999]) prior to the outbreak, respectively. We observed frequent de novo evolution of MDR and XDR, with 56 and nine independent evolutionary events, respectively. Isoniazid resistance evolved before rifampicin resistance 46 times, whereas rifampicin resistance evolved prior to isoniazid only twice. We identified additional putative compensatory mutations to rifampicin in this dataset. One major limitation of this study is that the conclusions with respect to ordering and timing of acquisition of mutations may not represent universal patterns of drug resistance emergence in other areas of the globe. CONCLUSIONS: In the first whole genome-based analysis of the emergence of drug resistance among clinical isolates of M. tuberculosis, we show that the ancestral precursor of the LAM4 XDR outbreak strain in Tugela Ferry gained mutations to first-line drugs at the beginning of the antibiotic era. Subsequent accumulation of stepwise resistance mutations, occurring over decades and prior to the explosion of HIV in this region, yielded MDR and XDR, permitting the emergence of compensatory mutations. Our results suggest that drug-resistant strains circulating today reflect not only vulnerabilities of current TB control efforts but also those that date back 50 y. In drug-resistant TB, isoniazid resistance was overwhelmingly the initial resistance mutation to be acquired, which would not be detected by current rapid molecular diagnostics employed in South Africa that assess only rifampicin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
(1996) · Cited by 20,179
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models
Stamatakis, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl446 · Cited by 15,582
Bayesian Phylogenetics with BEAUti and the BEAST 1.7
Drummond, A. J., Suchard, M. A., Xie, D., & Rambaut, A. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss075 · Cited by 10,063
Walker, B. J., Abeel, T., Shea, T., Priest, M., Abouelliel, A., Sakthikumar, S., Cuomo, C. A., Zeng, Q., Wortman, J., Young, S. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112963 · Cited by 9,197
Self-citationRapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Variable host–pathogen compatibility in Mycobacterium tuberculosis
Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B. C., Narayanan, S., Nicol, M., Niemann, S., Kremer, K., Gutierrez, M. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511240103 · Cited by 971
Walker, T. M., Ip, C. L., Harrell, R. H., Evans, J. T., Kapatai, G., Dedicoat, M. J., Eyre, D. W., Wilson, D. J., Hawkey, P. M., Crook, D. W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70277-3 · Cited by 918
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
A robust SNP barcode for typing Mycobacterium tuberculosis complex strains
Coll, F., McNerney, R., Guerra-Assunção, J. A., Glynn, J. R., Perdigão, J., Viveiros, M., Portugal, I., Pain, A., Martin, N., & Clark, T. G. (2014) · Nature Communications · doi:10.1038/ncomms5812 · Cited by 697
zt: A Software Tool for Simple and Partial Mantel Tests
Bonnet, E., & Van de Peer, Y. (2002) · Journal of Statistical Software · doi:10.18637/jss.v007.i10 · Cited by 696
High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography
Hershberg, R., Lipatov, M., Small, P. M., Sheffer, H., Niemann, S., Homolka, S., Roach, J. C., Kremer, K., Petrov, D. A., Feldman, M. W., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060311 · Cited by 593
Comas, I., Borrell, S., Roetzer, A., Rose, G., Malla, B., Kato-Maeda, M., Galagan, J., Niemann, S., & Gagneux, S. (2012) · Nature Genetics · doi:10.1038/ng.1038 · Cited by 572
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
Merker, M., Blin, C., Mona, S., Duforet-Frebourg, N., Lecher, S., Willery, E., Blum, M. G. B., Rüsch-Gerdes, S., Mokrousov, I., Aleksic, E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3195 · Cited by 543
Roetzer, A., Diel, R., Kohl, T. A., Rückert, C., Nübel, U., Blom, J., Wirth, T., Jaenicke, S., Schuback, S., Rüsch-Gerdes, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001387 · Cited by 482
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Casali, N., Nikolayevskyy, V., Balabanova, Y., Harris, S. R., Ignatyeva, O., Kontsevaya, I., Corander, J., Bryant, J., Parkhill, J., Nejentsev, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2878 · Cited by 473
Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M., & Fortune, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2656 · Cited by 457
Demay, C., Liens, B., Burguière, T., Hill, V., Couvin, D., Millet, J., Mokrousov, I., Sola, C., Zozio, T., & Rastogi, N. (2012) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2012.02.004 · Cited by 445
Farhat, M. R., Shapiro, B. J., Kieser, K. J., Sultana, R., Jacobson, K. R., Victor, T. C., Warren, R. M., Streicher, E. M., Calver, A., Sloutsky, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2747 · Cited by 440
Self-citationFord, C. B., Lin, P. L., Chase, M. R., Shah, R. R., Iartchouk, O., Galagan, J., Mohaideen, N., Ioerger, T. R., Sacchettini, J. C., Lipsitch, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.811 · Cited by 437
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Zhang, H., Li, D., Zhao, L., Fleming, J., Lin, N., Wang, T., Liu, Z., Li, C., Galwey, N., Deng, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2735 · Cited by 429
Global tuberculosis drug development pipeline: the need and the reality
Ma, Z., Lienhardt, C., McIlleron, H., Nunn, A. J., & Wang, X. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-9 · Cited by 374
Extensively drug-resistant tuberculosis
Jassal, M., & Bishai, W. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70260-3 · Cited by 312
Self-citationCompensatory Evolution in Rifampin-Resistant Escherichia coli
Reynolds, M. G. (2000) · Genetics · doi:10.1093/genetics/156.4.1471 · Cited by 266
Guerra-Assunção, J., Crampin, A., Houben, R., Mzembe, T., Mallard, K., Coll, F., Khan, P., Banda, L., Chiwaya, A., Pereira, R., et al. (2015) · eLife · doi:10.7554/elife.05166 · Cited by 257
Reducing antibiotic resistance
Schrag, S. J., & Perrot, V. (1996) · Nature · doi:10.1038/381120b0 · Cited by 254
A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control
Churchyard, G. J., Fielding, K. L., Lewis, J. J., Coetzee, L., Corbett, E. L., Godfrey-Faussett, P., Hayes, R. J., Chaisson, R. E., & Grant, A. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1214289 · Cited by 238
Walker, T. M., Lalor, M. K., Broda, A., Ortega, L. S., Morgan, M., Parker, L., Churchill, S., Bennett, K., Golubchik, T., Giess, A. P., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70027-x · Cited by 221
de Vos, M., Müller, B., Borrell, S., Black, P. A., van Helden, P. D., Warren, R. M., Gagneux, S., & Victor, T. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01541-12 · Cited by 219
Tuberculosis therapy: past, present and future
Iseman, M. D. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00309102 · Cited by 207
Safi, H., Lingaraju, S., Amin, A., Kim, S., Jones, M., Holmes, M., McNeil, M., Peterson, S. N., Chatterjee, D., Fleischmann, R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2743 · Cited by 205
Bryant, J. M., Schürch, A. C., van Deutekom, H., Harris, S. R., de Beer, J. L., de Jager, V., Kremer, K., van Hijum, S. A. F. T., Siezen, R. J., Borgdorff, M., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-110 · Cited by 197
Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain
Eldholm, V., Monteserin, J., Rieux, A., Lopez, B., Sobkowiak, B., Ritacco, V., & Balloux, F. (2015) · Nature Communications · doi:10.1038/ncomms8119 · Cited by 188
Genetic Manipulation of Mycobacterium tuberculosis
Larsen, M. H., Biermann, K., Tandberg, S., Hsu, T., & Jacobs (2007) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc10a02s6 · Cited by 185
Ioerger, T. R., Koo, S., No, E.-G., Chen, X., Larsen, M. H., Jacobs, W. R., Pillay, M., Sturm, A. W., & Sacchettini, J. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007778 · Cited by 165
Gandhi, N. R., Weissman, D., Moodley, P., Ramathal, M., Elson, I., Kreiswirth, B. N., Mathema, B., Shashkina, E., Rothenberg, R., Moll, A. P., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis631 · Cited by 133
Cohen, T., Lipsitch, M., Walensky, R. P., & Murray, M. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600349103 · Cited by 126
McEvoy, C. R. E., Cloete, R. E. A., Müller, B., Schürch, A. C., van Helden, P. D., Gagneux, S., Warren, R. M., & van Pittius, N. C. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030593 · Cited by 122
Cattamanchi, A., Dantes, R., Metcalfe, J. Z., Jarlsberg, L. G., Grinsdale, J. A., Kawamura, L. M., Osmond, D. H., Hopewell, P. C., & Nahid, P. (2008) · Clinical Infectious Diseases · doi:10.1086/595689 · Cited by 114
Song, T., Park, Y., Shamputa, I. C., Seo, S.-H., Lee, S. Y., Jeon, H.-S., Choi, H., Lee, M., Glynne, R. J., Barnes, S. W., et al. (2014) · Molecular Microbiology · doi:10.1111/mmi.12520 · Cited by 100
AMELIORATION OF THE DELETERIOUS PLEIOTROPIC EFFECTS OF AN ADAPTIVE MUTATION INBACILLUS SUBTILIS
Cohan, F. M., King, E. C., & Zawadzki, P. (1994) · Evolution · doi:10.1111/j.1558-5646.1994.tb01296.x · Cited by 97
Chihota, V. N., Müller, B., Mlambo, C. K., Pillay, M., Tait, M., Streicher, E. M., Marais, E., van der Spuy, G. D., Hanekom, M., Coetzee, G. J., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05832-11 · Cited by 59
Neisseria meningitidisSerogroup W, Burkina Faso, 2012
MacNeil, J. R., Médah, I., Koussoubé, D., Novak, R. T., Cohn, A. C., Diomandé, F. V. K., Yelbeogo, D., Kambou, J. L., Tarbangdo, F., Ouedraogo-Traoré, R., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2003.131407 · Cited by 58
Müller, B., Chihota, V. N., Pillay, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070919 · Cited by 52
Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
Wallengren, K., Scano, F., Nunn, P. P., Margot, B., Buthelezi, S. J., Williams, B. G., Pym, A. S., Samuel, E. Y., Mirzayev, F., Nkhoma, W., et al. (2011) · Emerging infectious diseases · doi:10.3201/eid1710.100952 · Cited by 51
Self-citationMills, H. L., Cohen, T., & Colijn, C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005260 · Cited by 51
O’Donnell, M. R., Wolf, A., Werner, L., Horsburgh, C. R., & Padayatchi, N. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000221 · Cited by 49
Self-citationA native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
Lasagna‐Reeves, C. A., Rousseaux, M. W. C., Guerrero‐Munoz, M. J., Park, J., Jafar‐Nejad, P., Richman, R., Lü, N., Sengupta, U., Litvinchuk, A., Orr, H. T., et al. (2015) · eLife · doi:10.7554/elife.07558 · Cited by 43
Minimal Diversity of Drug-ResistantMycobacterium tuberculosisStrains, South Africa1
Gandhi, N. R., Brust, J. C. M., Moodley, P., Weissman, D., Heo, M., Ning, Y. M., Moll, A. P., FRIEDLAND, G. H., Sturm, A. W., & Shah, N. (2014) · Emerging infectious diseases · doi:10.3201/eid2003.131083 · Cited by 40
Mvelase, N. R., Werner, L., Phili, R., Cele, L. P., & Mlisana, K. P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-442 · Cited by 40
Self-citationDenkinger, C. M., Pai, M., & Dowdy, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084197 · Cited by 35
Genomic Epidemiology of Multidrug-ResistantMycobacterium tuberculosisDuring Transcontinental Spread
Coscollá, M., Barry, P. M., Oeltmann, J. E., Koshinsky, H. A., Shaw, T., Cilnis, M., Posey, J., Rose, J., Weber, T., Fofanov, V. Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv025 · Cited by 34
O’Donnell, M. R., Pym, A. S., Jain, P., Munsamy, V., Wolf, A., Karim, F., Jacobs, W. R., & Larsen, M. H. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03530-14 · Cited by 31
Self-citation
Cited by
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citationEllington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux011 · Cited by 457
Fast and flexible bacterial genomic epidemiology with PopPUNK
Lees, J. A., Harris, S. R., Tonkin-Hill, G., Gladstone, R. A., Lo, S. W., Weiser, J. N., Corander, J., Bentley, S. D., & Croucher, N. J. (2019) · Genome Research · doi:10.1101/gr.241455.118 · Cited by 438
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
Meehan, C. J., Goig, G. A., Kohl, T. A., Verboven, L., Dippenaar, A., Ezewudo, M., Farhat, M. R., Guthrie, J. L., Laukens, K., Miotto, P., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0214-5 · Cited by 422
Metadata
- Authors
- Cohen, K. A., Abeel, T., Manson McGuire, A., Desjardins, C. A., Munsamy, V., Shea, T. P., Walker, B. J., Bantubani, N., Almeida, D. V., Alvarado, L., Chapman, S. B., Mvelase, N. R., Duffy, E. Y., Fitzgerald, M. G., Govender, P., Gujja, S., Hamilton, S., Howarth, C., Larimer, J. D., Maharaj, K., Pearson, M. D., Priest, M. E., Zeng, Q., Padayatchi, N., Grosset, J., Young, S. K., Wortman, J., Mlisana, K. P., O'Donnell, M. R., Birren, B. W., Bishai, W. R., Pym, A. S., & Earl, A. M.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-29
- Volume
- 12
- Issue
- 9
- Pages
- e1001880
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2124249157
- Cited by
- 274
- References
- 55
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.